Market View (Fall 2019) – Ethics in Biotechnology: Just Because We Can …

  |  October 22, 2019

Perhaps one of the most interesting discoveries in modern history was the structure of DNA. As we continue to study our genetic makeup, we are making fascinating discoveries about history, physiology, and disease. CRISPR technology is allowing us to make changes to the genetic structure of plants and animals. And as the technology improves, we can see potential benefits for humans ...Read more. Read More

Market View (April 2019) – Rules vs. Principles: A Talk by Andrew Fastow

  |  April 17, 2019

The CFA Society of New Mexico recently hosted a fireside chat by Andrew Fastow, the former CFO of Enron. Mr. Fastow began the time by acknowledging that what he did was wrong, unethical, and illegal. He also took full responsibility for his actions and apologized.

For the rest of his talk, however, Mr. Fastow did not focus on Enron, but rather the way we work to rationalize questionable behavior. Mr. Fastow led us through a few thought exercises that might appear to be unethical, but upon further examination and with a little more information were actually examples of routine business practices. Read more. Read More

Market View (January 2019) – This Might Sting a Little

  |  January 30, 2019

“This might sting a little,” “You might feel some discomfort,” “You might experience some pain,” these phrases are meant to prepare and supposedly ease imminent pain from a needle or other medical procedure, but somehow they often do not. I suspect that as you read those phrases you almost immediately remembered an unpleasant experience. Read more. Read More

Market View (October 2018) – Volatility: Déjà vu All Over Again

  |  October 12, 2018

In the first two week of October 2018, we have seen a fairly rapid decline in market values. At the time of this writing, the S&P 500 has declined about 6.2% during the month of October with developed international equities performing in a similar fashion and emerging market equities performing worse. Ostensibly, it is valuations, rising interest rates and trade tariffs that are to blame. We added “déjà vu all over again” to the title, because we were in a similar situation as our February 2018 newsletter. Read more. Read More